April 26, 2018 / 6:11 AM / 3 months ago

BRIEF-Mereo Biopharma Group withdraws proposed Nasdaq listing

April 26 (Reuters) - Mereo Biopharma Group PLC:

* COMPANY HAS WITHDRAWN GLOBAL OFFERING AND POSTPONED ITS PROPOSED LISTING OF ITS AMERICAN DEPOSITARY SHARES (“ADSS”) ON NASDAQ GLOBAL MARKET THAT WAS PREVIOUSLY ANNOUNCED ON APRIL 9, 2018

* COMPANY BELIEVES THAT CURRENT MARKET CONDITIONS ARE NOT CONDUCIVE FOR AN OFFERING ON TERMS THAT WOULD BE IN BEST INTERESTS OF ITS SHAREHOLDERS.

* DENISE SCOTS-KNIGHT, CHIEF EXECUTIVE OFFICER OF MEREO BIOPHARMA GROUP PLC COMMENTED: “WE RECEIVED POSITIVE FEEDBACK AND STRONG LEVELS OF INSTITUTIONAL INTEREST DURING OFFERING PROCESS Source text for Eikon: Further company coverage: (Reporting by Emma Rumney)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below